Thomas J. Jentsch is a leading Professor at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, with secondary affiliation to the Max Delbrück Center (MDC) . He holds dual doctorates in Medicine and Physics from Freie Universität Berlin and has pioneered research in ion transport physiology since co-founding the Center for Molecular Neurobiology Hamburg in 1988. Head of Jentsch Group at FMP since 2006 World leader in chloride channel research His research bridges molecular physiology and human genetics , focusing on: CLC family chloride channels/transporters VRAC/LRRC8 volume-regulated channels ASOR/TMEM206 acid-activated channels Pathologies: neurodegeneration, deafness, osteopetrosis, hypertension Recent work includes breakthroughs in VRAC channel structure (2023) and CLCN7 channelopathies (2024). His lab employs genetically modified mouse models and human mutation analysis to uncover disease mechanisms.
Anna E. Beaudin is an Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine, holding an adjunct appointment in the Department of Pathology's Division of Microbiology and Immunology. Her research centers on fetal hematopoiesis and its lifelong impact on immune function and disease susceptibility. Her educational background includes: B.A. from Cornell University M.S. from Brown University Ph.D. from Cornell University Dr. Beaudin's work investigates how fetal hematopoietic stem cells generate specialized immune cells that persist into adulthood to maintain tissue homeostasis. She examines how prenatal challenges like infection and nutrition disrupt immune development, leading to conditions such as asthma, metabolic disorders, and hearing loss. Her lab employs single-cell analysis, fate-mapping, and mouse models to uncover mechanisms of developmental hematopoiesis. Recent publications reveal a dominant theme: prenatal inflammation and nutritional factors reprogram hematopoietic stem cells, altering immune cell development and increasing susceptibility to allergic, metabolic, and autoimmune diseases across the lifespan. Key focus areas include tissue-resident macrophages, innate lymphoid cells, and fetal-specific hematopoietic pathways. Her scientific recognition includes: Pew Biomedical Scholars Award Hellman Foundation Award Research is supported by NIH grants and published in high-impact journals including Cell Stem Cell and Blood. As Principal Investigator, she mentors graduate students through the Molecular Biology Program and serves on committees for the International Society of Experimental Hematology and American Society of Hematology. Her work involves extensive collaboration with immunologists, hematologists, and developmental biologists. The Beaudin Lab operates within the University of Utah's Molecular Medicine Program, utilizing advanced genomic and in vivo techniques to explore how early-life events shape lifelong immunity and disease risk.
Maoli Duan is an Associate Professor and Senior Consultant at the Karolinska Institutet , affiliated with the Department of Clinical Science, Intervention and Technology under the Ear, Nose and Throat Diseases division. With over 150 peer-reviewed publications, his translational research bridges animal models and clinical applications in otolaryngology. Academic Rank: Associate Professor (Karolinska Institutet, 2006) Doctoral Degree: Department of Physiology and Pharmacology, Karolinska Institutet (1999) Research Focus Dr. Duan's work centers on gene therapy and stem cell treatments for sensorineural hearing loss , with recent breakthroughs in AAV vector delivery for congenital deafness. His 2025 Nature Medicine study demonstrated hearing restoration in patients with OTOF gene mutations through viral gene replacement. Publication Trends His 15 most recent articles (2023-2025) span biomedical engineering , clinical otology , and translational neuroscience . Key subfields include inner ear drug delivery , cochlear implants , gene therapy protocols , and viral vector optimization . Notably, his team has pioneered non-invasive approaches to treating Meniere's disease and noise-induced hearing loss . Collaborative Networks Dr. Duan collaborates with institutions across Europe , Asia , and North America , with recurring co-authors from Karolinska Institutet , University of Gothenburg , and Shanghai Jiao Tong University . His work appears in Nature Medicine , PNAS , and Advanced Science . Scientific Context Dr. Duan's research aligns with global efforts to address genetic hearing disorders through molecular interventions. His team's clinical trials demonstrate that gene therapy can restore near-normal hearing in OTOF mutation carriers without major adverse events, opening new pathways for non-invasive auditory restoration in both pediatric and adult populations.
Carey D. Balaban is a Professor at the University of Pittsburgh with joint appointments across multiple departments including Otolaryngology-Head & Neck Surgery, Neurobiology, Communication Science & Disorders, and Bioengineering, reflecting his highly interdisciplinary research profile. His work bridges biomedical sciences, engineering, and clinical applications with significant contributions to vestibular neuroscience and related disorders. Dr. Balaban earned his BA in History from Michigan State University, PhD in Anatomy from the University of Chicago, and completed postdoctoral training at the University of Tokyo. His educational background uniquely informs his dual expertise in historical medicine and contemporary neuroscience. His research focuses on mathematical and heuristic modeling of neurological and psychological features in balance disorders, migraine, and anxiety. He has pioneered translational approaches examining co-morbid aspects of vestibular disorders and developed novel methodologies including mass spectrometric imaging of histological materials. Current work extends these models to mild traumatic brain injury and acoustic trauma. Dr. Balaban's publications reveal consistent contributions to vestibular neuroscience, with recent work (through 2025) focusing on third window syndromes, vestibular migraine, and neuro-otological aspects of anxiety disorders. His research demonstrates strong translational impact with patented technologies for assessing situational awareness and cognitive engagement. He teaches core courses for the National Preparedness and Homeland Security certificate program, Medical Neurobiology, undergraduate History of Medicine, and graduate Intellectual History of Neuroscience, demonstrating remarkable breadth across scientific and humanities disciplines. His authorship of two books on seventeenth century medicine further highlights this unique interdisciplinary perspective. Dr. Balaban maintains active research collaborations across multiple institutions, with frequent co-authorship patterns indicating strong partnerships in neuro-otology, particularly with researchers at military medical centers given his work on posttraumatic dizziness and mass casualty response systems.
John V. Brigande is an Associate Professor at the Oregon Hearing Research Center, Oregon Health & Science University. He began his academic career at Boston College where he earned his B.S. (1987), M.S. (1991), and Ph.D. (1997) in neuroscience and developmental neurobiology. His postdoctoral training included developmental genetics at the University of Texas at Austin (1998) and auditory development at Purdue University (2003). He joined the Oregon Hearing Research Center as an Assistant Professor in 2003 and was promoted to Associate Professor in 2009. Since 2011, he has been a key contributor to the Hearing Health Foundation's Hearing Restoration Project. Education: B.S., Boston College, 1987 M.S., Boston College, 1991 Ph.D., Boston College, 1997 Postdoctoral Fellowship, University of Texas at Austin, 1998 Postdoctoral Fellowship, Purdue University, 2003 Brigande's research focuses on mammalian inner ear development , employing experimental embryology, surgical techniques, and gene transfer methods to study developmental processes in vivo. His lab investigates cell fate decisions in otic progenitors using retroviral lineage analysis and develops fetal gene/drug therapies for congenital deafness. A major focus is translating developmental mechanisms into gene and cell therapies for hearing loss and balance disorders, with particular emphasis on hair cell regeneration strategies. His publications demonstrate a strong focus on translational approaches to hearing restoration , including gene therapy (CRISPR/Cas9, AAV vectors), antisense oligonucleotides for congenital disorders, and optimization of diagnostic techniques. Recent work explores primate models of Usher syndrome, fetal pharmacotherapy, and mitochondrial genetics, reflecting interdisciplinary collaboration across genetics, audiology, and developmental biology. Brigande leads a research laboratory within the Hearing Health Foundation's Hearing Restoration Project consortium, focused on developing mouse model systems to validate hair cell regeneration candidates. The lab utilizes techniques including transuterine microinjection, in vivo electroporation, and single-cell transcriptomics to advance therapeutic strategies for inner ear disorders.
Anthony Cacace is Professor of Audiology in the Department of Communication Sciences and Disorders at Wayne State University's College of Liberal Arts and Sciences. Formerly tenured faculty at Albany Medical College in Surgery and Neurology, he directed clinical programs including the Audiology Department and Hearing Rehabilitation Center. His expertise spans psychoacoustics, electrophysiology, vestibular assessment, and neuroimaging techniques for tinnitus and auditory processing disorders. Dr. Cacace's educational background includes: B.S. in Speech Pathology and Audiology, State University of New York (1974) M.S. in Audiology, Syracuse University (1975) Ph.D. in Communication Sciences and Disorders/Audiology, Syracuse University (1988) Post Doctoral Fellowship in Neurophysiology, Wadsworth Center (1987) His research focuses on Central Auditory Processing Disorder, tinnitus mechanisms, and noise-induced vestibular dysfunction using TMS, MRI, and electrophysiological methods. Current work investigates blast injury consequences in veterans through VA/DoD-funded projects. Recent publications reveal strong emphasis on tinnitus neuroimaging, auditory processing disorder diagnostics, and vestibular-blast injury relationships. His work integrates diffusion tensor imaging, nanotheranostics, and electrophysiological biomarkers to advance diagnostic and therapeutic frameworks. Scientific recognition includes: ASHA Fellowship (1997) American Academy of Audiology Fellowship (1991) As primary capstone supervisor, Dr. Cacace mentors graduate students while leading multi-institutional research: VA Merit Awards ($1.5M+) on tinnitus and vestibular blast injuries NIH R21 nanotheranostics grant ($141k) Wayne State Omnibus Grants for vestibular/gait equipment He collaborates with Wayne State's Neurosciences Institute, VA Medical Center, and University of Michigan teams studying veteran auditory-vestibular health.
Ashley Parker is a Visiting Assistant Professor in the Department of Communication Science and Disorders at the University of Pittsburgh’s School of Health and Rehabilitation Sciences (SHRS), where she joined as a Postdoctoral Associate in 2022 and transitioned to a faculty role in 2024. She has extensive experience teaching hearing sciences at both the University of Pittsburgh and the University of Connecticut. Ph.D., Speech, Language and Hearing Sciences, University of Connecticut M.A., Linguistics, Indiana University B.A., English and Secondary Education Her research lies at the intersection of audiology and neuroscience, focusing on hearing loss , biomarkers of hearing , and auditory electrophysiology . She investigates physiological indicators such as prestin in blood and their correlation with functional measures like otoacoustic emissions and auditory brainstem responses. Her work bridges laboratory findings with real-world hearing environments. The recent publications reflect a strong trend in identifying non-invasive biomarkers for cochlear health, particularly serological prestin, and validating hearing assessment tools outside clinical settings. Her research contributes to early detection of noise-induced hearing damage and improves diagnostic accessibility through home-based testing paradigms. Dr. Parker has been recognized with competitive awards: National Institutes of Health Loan Repayment Program Awardee ASHFoundation Audiology Student Grant She actively contributes to academic training in hearing sciences and is involved in translational research aimed at improving audiological diagnostics and interventions. While no formal advisees are listed, her mentorship is evident through grant-funded research and collaborative publications. Her work is supported by federal and foundation-level recognition, indicating strong potential for future independent research.
Prof. Karen B. Avraham serves as Professor and Dean of the Gray Faculty of Medical & Health Sciences at Tel Aviv University, holding the Drs. Sarah and Felix Dumont Chair for Research of Hearing Disorders. Her laboratory operates within the Department of Human Molecular Genetics & Biochemistry. Her research centers on genomics of deafness and developmental delay , utilizing advanced methodologies including AI-driven gene discovery, CRISPR-based gene editing, drug repurposing, and epigenomic regulation studies. The lab employs state-of-the-art imaging tools like confocal and electron microscopy to investigate hearing impairment pathophysiology from genetic variants. Recent publication trends reveal strong focus on translational genomics , with significant work on mouse models of human disorders (GRIN2D encephalopathy, SMARCA4-related otosclerosis) and computational approaches to rare disease gene annotation. Her team actively participates in major international conferences including the Inner Ear Biology Workshop and Association for Research in Otolaryngology meetings. The laboratory maintains active research funding including support from the Klass Family and hosts post-doctoral trainees specializing in genomics techniques. Current leadership includes Ms. Helen Berman as Administrative Assistant.
Marianne Bronner is the Edward B. Lewis Professor of Biology and Director of the Beckman Institute at the California Institute of Technology. She holds a Sc.B. from Brown University (1975) and a Ph.D. from Johns Hopkins University (1979). Her career at Caltech spans roles including Ruddock Professor (2000-21), Distinguished Professor (2021), and Executive Officer (2013-16). Her research focuses on neural crest development, integrating molecular, cellular, and evolutionary approaches. Key areas include neural crest induction, placode formation, and their roles in craniofacial and sensory organ development. She explores evolutionary innovations like the vertebrate head by comparing lamprey, amphioxus, and jawed vertebrates. Her lab investigates mechanisms of cell migration, epigenetic regulation, and oncogenic processes linked to neural crest-derived cancers. Techniques employed include transcriptomics, CRISPR/Cas9, laser speckle imaging, and lineage tracing in chick, zebrafish, and lamprey models. Recent work highlights neural crest contributions to heart regeneration and neurofibromatosis modeling in zebrafish. The lab collaborates with the Caltech Women in STEM initiative and has pioneered tools for in vivo imaging and genetic manipulation. Lab Leadership: Bronner Lab at Caltech Key Projects: Neural crest gene regulatory networks, placode evolution, cancer biology Tools: Laser speckle imaging, CRISPR, lineage tracing Her work bridges developmental, evolutionary, and translational research, with implications for birth defects, cancer, and regenerative medicine.
Takako Makita, PhD, is an Assistant Professor in the Department of Regenerative Medicine and Cell Biology at the Medical University of South Carolina (MUSC) College of Medicine. Her research focuses on molecular mechanisms controlling peripheral nervous system (PNS) development, particularly in heart innervation, enteric nervous system formation, and congenital disorders like Waardenburg-Shah syndrome. She employs mouse genetics, physiological assessments, and molecular biology to study signaling pathways in neural development. Education: B.S. in Chemistry, Tokyo Metropolitan University (1994) Ph.D. in Biochemistry and Molecular Biology, University of Southern California Keck School of Medicine (2004) Postdoctoral Fellowship at Johns Hopkins University (2005–2009) Research Interests: Molecular mechanisms of PNS circuitry, sympathetic axon guidance to the heart, enteric nervous system migration, and genetic loci contributing to congenital deafness. Current projects include investigating heart arrhythmia mechanisms, Waardenburg-Shah syndrome genetic screens, and sympathetic synapse formation in heart/kidney systems. Lab Work: Her lab uses mouse models and molecular approaches to dissect neural development pathways. Key collaborations include studies on cardiomyocyte regeneration, enteric neuron degeneration, and genetic therapies for lysosomal storage disorders.
Barbara Canlon is Professor of Hearing Physiology at Karolinska Institutet, Department of Physiology and Pharmacology, with additional affiliations including Visiting Professor at Kyoto University Medical School (2008). She serves as President for both the Center for Communication Disorders (2005-present) and National Center for Communication Disorders (2005-present). Her research focuses on auditory neurobiology, specifically characterizing molecular mechanisms underlying hearing loss and identifying innovative protective strategies. Key areas include microscopic studies of cochlear hair cells and neurons, regenerative/damaging agents for hair cells, and stress physiology epidemiology related to hearing impairment. She investigates both long-term and short-term stress impacts on auditory function. Dr. Canlon has delivered over 35 plenary talks internationally, including at ISAAR Denmark (2011), CRS Amplifon Germany (2011), and the 50-year anniversary of Kresege Hearing Institute at University of Michigan (2010). Her work bridges clinical applications and fundamental research in otolaryngology. Alvarengas Prize (1990) for discovering Sound Induced Outer Hair Cell Motility C. A. Tegnér Prize for Ocular Transplants of the Inner Ear (1992) Elected Vice-President for Swedish Acoustical Society (1998-present) Elected into CORLAS (2006) and 13-Club (2007) Fulbright Commission Board Member (2010) Editor-in-Chief for Hearing Research (2010) She has secured major funding including European Commission Concerted Action grants (1995, 2000) as Task Organizer, served as Principal Investigator for the Research School on Communication Disorders (2009-2014), and consulted for NIH (1994), AstraZeneca (2010 workplace hearing studies), and United States Marines (2011). Her leadership extends to the International Committee Research in Otolaryngology (1998) and consortiums for Hearing Disabilities (2009).
Kimberlee Giffen is an Assistant Professor in the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia . Her academic work focuses on molecular mechanisms underlying sensory cell survival and degeneration. Ph.D. in Biomedical Sciences, Creighton University (2020) Master of Teaching, Grand Canyon University (2008) B.S. in Biology, University of Northern Colorado (2003) Research spans: Molecular profiling of cochlear aging Lysosomal dysfunction in auditory neuropathy Transcriptional regulation of inner ear development Evolutionary conservation of gene expression Publication trends reveal focus on auditory neuroscience, molecular pathology, and cross-species genetic analysis. Teaches graduate courses in clinical anatomy, renal/cardiopulmonary systems, GI/endocrinology, reproductive biology, and foundational medical sciences.
Nicolas Verhaert is a Professor at the Faculty of Medicine, KU Leuven, and head of the Experimental Otorhinolaryngology Research Group. He is actively affiliated with the KU Leuven Brain Institute (LBI) and Cancer Institute (LKI), and participates in the Faculty Council of Medicine and Departmental Council of Neurosciences. His research focuses on otogenetic studies, regenerative hearing solutions, and advanced hearing implants. His research interests span otology , neurotology , and hearing mechanics , with a specific emphasis on cochlear implants , bone conduction devices , and vestibular function . Recent publications highlight innovations in intraoperative trauma detection , vestibular implant stability , and genetic hearing loss . His work integrates biomedical engineering , neuroscience , and clinical otorhinolaryngology . Key trends in his publications include Development of in vivo biosensors for real-time inflammation monitoring Advancements in robot-assisted cochlear implantation Optimization of bone conduction electrode placement Longitudinal analysis of genetic speech perception deficits Systematic reviews on inner ear pharmacotherapy He supervises research projects involving students such as J. Wellens and E. Loos, and his team collaborates with institutions like the KU Leuven Brain Institute . The Experimental Otorhinolaryngology Research Group focuses on translational insights into cochlear mechanics, imaging, and biosensors.
Jinkyung Kim, PhD, serves as Assistant Professor of Otolaryngology—Head & Neck Surgery at Washington University School of Medicine in St. Louis, where she leads innovative research on cochlear function and hearing preservation. Her academic journey includes: Postdoctoral Training: Department of Otolaryngology, Stanford University School of Medicine (2020) PhD: School of Interdisciplinary Bioscience and Bioengineering, POSTECH, Pohang, Republic of Korea (2012) BS: Life Science, Chung-Ang University, Seoul, Republic of Korea (2006) Dr. Kim pioneers in vivo two-photon imaging techniques to monitor real-time multicellular activity in the cochlea of hearing-preserved mice, overcoming historical barriers in inner ear physiology research. Her lab focuses on decoding sound processing mechanisms along the auditory pathway and identifying transport routes for ototoxic drugs to develop targeted blockers that prevent chemotherapy-induced hearing loss. This work bridges cellular neuroscience with clinical otology through advanced surgical methodologies. Her scientific contributions have been recognized with: Cozzarelli Prize from Proceedings of the National Academy of Sciences (2023) Travel Award from The Association for Research in Otolaryngology (2016) Best Oral Presentation Award from The Korean Society for Brain and Neural Science (2012) The Kim Lab operates as a specialized neuroscience research unit dedicated to transforming auditory physiology through direct observation of cochlear dynamics, with implications for developing clinical interventions to protect hearing during ototoxic drug treatments.
J. Christopher Holt is an Associate Professor in the Department of Otolaryngology at the University of Rochester School of Medicine and Dentistry. He leads the Holt Lab, which focuses on the synaptic pharmacology of the vestibular apparatus, investigating how efferent feedback mechanisms modulate sensory input to the brain. Education: Ph.D. in Pharmacology from Tulane University School of Medicine (1994-1999) Postdoctoral Training at University of Chicago (2000-2005) M.S. in Biology from University of Louisiana at Monroe (1991-1994) B.S. in Biology and Chemistry from University of North Carolina at Pembroke (1986-1991) Holt's research centers on the cellular and molecular mechanisms of synaptic transmission in the vestibular periphery. His work examines how efferent feedback mechanisms modulate sensory information regarding head position and movement. The vestibular system, which begins as small detectors in the inner ear, is endowed with prominent efferent innervation whose functional role is relatively unknown. Holt's lab takes a reductionistic approach to address vestibular efferent system function from multiple vantage points: identifying receptor mechanisms, characterizing how these mechanisms modulate afferent response properties, identifying efferent discharge patterns, and developing behavioral assays for monitoring vestibular efferent function. His recent publications reveal a consistent focus on cholinergic mechanisms in vestibular function, with particular attention to how efferent pathways modulate afferent responses. There's a clear progression from basic mechanistic studies in animal models toward understanding these processes in mammals, including humans. A significant theme across his work is the role of specific receptor types (particularly nicotinic and muscarinic acetylcholine receptors) and their downstream effectors in generating different afferent responses to efferent stimulation. Scientific Awards: Advanced Predoctoral Fellowship (1997-1999) James F. Ebert Award (1989) J.P. Stevens Scholarship (1989-1990) Chancellor's Scholar Program (1986-1991) Holt mentors graduate students and postdoctoral scholars in neurophysiological, pharmacological, and immunohistochemical methods for studying vestibular synaptic transmission. His lab provides training in multiple animal models and computational techniques for data analysis. The lab has multiple ongoing projects examining efferent receptors and synaptic mechanisms, modification of vestibular output during efferent stimulation, characterization of vestibular efferent neurons, and behavioral assessment of efferent function. The Holt Lab maintains strong affiliations with multiple departments and programs at the University of Rochester, including Neuroscience, the Del Monte Institute for Neuroscience, Cellular and Molecular Pharmacology and Physiology, and various PhD programs. This multidisciplinary approach allows for comprehensive investigation of vestibular function from molecular to behavioral levels.
